Apollomics(APLMW)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

APLMW Apollomics

盘前交易 12-15 09:25:33 EST

0.0168

+0.0005

+3.07%

盘前0.0169

+0.0001+0.60%

09:01 EST

最高0.0168	最低0.0110	成交量6.21万
今开0.0158	昨收0.0163	日振幅35.58%
总市值1.85万	流通市值1.85万	总股本110.33万
成交额897.35	换手率5.63%	流通股本110.33万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"APLMW","market":"US","secType":"STK","nameCN":"Apollomics","latestPrice":0.0168,"timestamp":1765573200000,"preClose":0.0163,"halted":0,"volume":62142,"hourTrading":{"tag":"盘前","latestPrice":0.0169,"preClose":0.0168,"latestTime":"09:01 EST","volume":100,"amount":1.69,"timestamp":1765807306245},"delay":0,"floatShares":1103333,"shares":1103333,"eps":0,"marketStatus":"盘前交易","change":0.0005,"latestTime":"12-15 09:25:33 EST","open":0.0158,"high":0.0168,"low":0.011,"amount":897.348315,"amplitude":0.355828,"askPrice":0.0219,"askSize":100,"bidPrice":0.0119,"bidSize":100,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765809000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0168,"preHourTrading":{"tag":"盘前","latestPrice":0.0169,"preClose":0.0168,"latestTime":"09:01 EST","volume":100,"amount":1.69,"timestamp":1765807306245},"volumeRatio":2.0497951630807196},"requestUrl":"/m/hq/s/APLMW/tweets","defaultTab":"tweets","newsList":[{"id":"2493725422","title":"Apollomics 公布在中国对复发或难治性急性髓系白血病患者进行的 Uproleselan III 期桥接试验主要结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2493725422","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493725422?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:13","pubTimestamp":1734718380,"startTime":"0","endTime":"0","summary":"试验未显示出 uproleselan 具有良好的疗效。Uproleselan 治疗组的严重不良事件发生率为 43%，单纯化疗组为 39%。Uproleselan 治疗组最常见的严重不良事件是血小板数量减少、感染性肺炎和败血症。2024 年 8 月，Apollomics 宣布减记与 uproleselan 项目预付款相关的无形资产。Apollomics 即将完成临床试验，预计 uproleselan 项目的未来费用将低于 50 万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/20/3000788/0/zh-hans/Apollomics-%E5%85%AC%E5%B8%83%E5%9C%A8%E4%B8%AD%E5%9B%BD%E5%AF%B9%E5%A4%8D%E5%8F%91%E6%88%96%E9%9A%BE%E6%B2%BB%E6%80%A7%E6%80%A5%E6%80%A7%E9%AB%93%E7%B3%BB%E7%99%BD%E8%A1%80%E7%97%85%E6%82%A3%E8%80%85%E8%BF%9B%E8%A1%8C%E7%9A%84-Uproleselan-III-%E6%9C%9F%E6%A1%A5%E6%8E%A5%E8%AF%95%E9%AA%8C%E4%B8%BB%E8%A6%81%E7%BB%93%E6%9E%9C.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLMW","III","BK4134"],"gpt_icon":0},{"id":"2493227424","title":"Apollomics 公布 Uproleselan 在中国治疗复发或难治性急性髓系白血病患者的第 3 期衔接性试验的主要结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2493227424","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493227424?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:13","pubTimestamp":1734718380,"startTime":"0","endTime":"0","summary":"该试验没有显示出对 uproleselan 有利的结果。Uproleselan 组严重不良事件的发生率为 43%，单独化疗组则为 39%。Uproleselan 组最常见的严重不良事件是血小板数量减少、感染性肺炎和败血症。在 2024 年 8 月，Apollomics 宣布降低与 uproleselan 项目预付款相关无形资产的账面价值。Apollomics 即将结束临床试验，预计 uproleselan 项目在未来的开销将低于 50 万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/20/3000788/0/zh-hant/Apollomics-%E5%85%AC%E5%B8%83-Uproleselan-%E5%9C%A8%E4%B8%AD%E5%9C%8B%E6%B2%BB%E7%99%82%E5%BE%A9%E7%99%BC%E6%88%96%E9%9B%A3%E6%B2%BB%E6%80%A7%E6%80%A5%E6%80%A7%E9%AB%93%E7%B3%BB%E7%99%BD%E8%A1%80%E7%97%85%E6%82%A3%E8%80%85%E7%9A%84%E7%AC%AC-3-%E6%9C%9F%E9%8A%9C%E6%8E%A5%E6%80%A7%E8%A9%A6%E9%A9%97%E7%9A%84%E4%B8%BB%E8%A6%81%E7%B5%90%E6%9E%9C.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLMW"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0769},{"period":"1month","weight":-0.1295},{"period":"3month","weight":0.1053},{"period":"6month","weight":-0.04},{"period":"1year","weight":0.697},{"period":"ytd","weight":0.8261}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"NASDAQ","name":"Apollomics","nameEN":"Apollomics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apollomics(APLMW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Apollomics(APLMW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Apollomics,APLMW,Apollomics股票,Apollomics股票老虎,Apollomics股票老虎国际,Apollomics行情,Apollomics股票行情,Apollomics股价,Apollomics股市,Apollomics股票价格,Apollomics股票交易,Apollomics股票购买,Apollomics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apollomics(APLMW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Apollomics(APLMW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}